NYSE:DGX • US74834L1008
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for QUEST DIAGNOSTICS INC (DGX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-12 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-11 | UBS | Maintains | Neutral -> Neutral |
| 2026-02-11 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-11 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-11 | Truist Securities | Maintains | Hold -> Hold |
| 2026-02-11 | Jefferies | Maintains | Buy -> Buy |
| 2026-02-10 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-27 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-10-22 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-22 | Truist Securities | Maintains | Hold -> Hold |
| 2025-10-21 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-10-21 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-08 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-10-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-25 | Baird | Downgrade | Outperform -> Neutral |
| 2025-07-23 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-23 | Deutsche Bank | Maintains | Hold -> Hold |
| 2025-07-23 | Truist Securities | Maintains | Hold -> Hold |
| 2025-07-18 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-06 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-04-28 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-04-23 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-23 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.252B -6.38% | 9.872B 6.70% | 11.035B 11.78% | 11.866B 7.53% | 12.313B 3.77% | 12.87B 4.52% | 13.13B 2.02% | N/A | |
| EBITDA YoY % growth | 1.755B -10.32% | 1.901B 8.32% | 2.221B 16.83% | 2.372B 6.80% | 2.507B 5.69% | 2.625B 4.71% | N/A | N/A | |
| EBIT YoY % growth | 1.316B -13.42% | 1.408B 6.99% | 1.651B 17.26% | 1.856B 12.42% | 1.981B 6.73% | 2.115B 6.76% | N/A | N/A | |
| Operating Margin | 14.22% | 14.26% | 14.96% | 15.64% | 16.09% | 16.43% | N/A | N/A | |
| EPS YoY % growth | 8.71 -12.20% | 9.02 3.56% | 9.85 9.20% | 10.74 9.04% | 11.55 7.53% | 12.60 9.10% | 14.29 13.43% | 14.16 -0.92% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.39 8.28% | 2.89 10.16% | 2.73 5.15% | 2.56 5.73% | 2.48 3.71% | 3.01 4.12% | 2.96 8.27% | 2.71 6.09% |
| Revenue Q2Q % growth | 2.855B 7.65% | 2.989B 8.26% | 2.936B 4.26% | 2.877B 2.53% | 2.906B 1.79% | 3.023B 1.14% | 3.044B 3.68% | 3.008B 4.55% |
| EBITDA Q2Q % growth | 543.75M 9.19% | 617.4M -17.24% | 583.93M -28.96% | 564.19M -42.95% | 572.57M 5.30% | 627.49M 1.63% | 614.18M 5.18% | 601.37M 6.59% |
| EBIT Q2Q % growth | 421.88M 17.84% | 496.13M 7.16% | 459.62M 15.77% | 439.77M 4.96% | 434.03M 2.88% | 504.09M 1.60% | 485.46M 5.62% | 463.08M 5.30% |
All data in USD
24 analysts have analysed DGX and the average price target is 220.47 USD. This implies a price increase of 12.91% is expected in the next year compared to the current price of 195.26.
QUEST DIAGNOSTICS INC (DGX) will report earnings on 2026-04-20, before the market open.
The consensus EPS estimate for the next earnings of QUEST DIAGNOSTICS INC (DGX) is 2.39 USD and the consensus revenue estimate is 2.85B USD.
The number of analysts covering QUEST DIAGNOSTICS INC (DGX) is 24.